REDEFINING THE PHARMA HCP CUSTOMERS RELATIONSHIPS

Size: px

Start display at page:

Download "REDEFINING THE PHARMA HCP CUSTOMERS RELATIONSHIPS"

Dominick Hoover
5 years ago
Views:

Y! O E A J IM M N T E R E D G A IES ITE N PA PH N IM TIO ILS PA L A A M R A I ST R D E T CO

PART OF REDEFINING THE PHARMA HCP CUSTOMERS RELATIONSHIPS KEYNOTE, INDUSTRY ADDRESS, AND

Transformation INNOVATION LABS ASIA Keynote: HO WENG SI Director, Biomedical Sciences Group

Manufacturing/Site Leader PROTEUS DIGITAL HEALTH, USA PLENARY SESSION THOUGHT LEADERS ENVER

Data & Technology Officer, Managing Director GLOBAL GENE CORP, MIGUEL ANGEL RIVERA TAPIA

Pacific Regional Director, Study Management and Logistics, SANOFI, Philippines HARISH DAVE

EXPERTS LAURENCE LIEW Director AI, JULIE OLSZEWSKI Executive Director, MSD Global Innovation

PETER TING Co-Founder, Cadiatrics, Senior Consultant Cardiologist, Gleneagles and Mt.

Roche, WINSTON CHEW Director, Regional Information Security Officer GlaxoSmithKline, TAMSIN

National University of, JASON TAMARA WIDJAJA Associate Director, Global Data Science (AI &

Laboratories, AARON TIAN Head of Neuroscience Patient Innovation UCB, China BRUCE SHI Chief

1 Y! O E A J IM M N T E R E D G A IES ITE N PA PH N IM TIO ILS PA L A A M R A I ST R D E T CO F O R E G O R 1 E F 1+ SE IBC LIFE SCIENCES September 2018 One Farrer Hotel & Spa, PART OF REDEFINING THE PHARMA HCP CUSTOMERS RELATIONSHIPS KEYNOTE, INDUSTRY ADDRESS, AND INNOVATION TALK Innovation Talk: SCOTT BALES Managing Director Innovation & Digital Transformation INNOVATION LABS ASIA Keynote: HO WENG SI Director, Biomedical Sciences Group ECONOMIC DEVELOPMENT BOARD, Industry Address: NIK LEIST Senior Director, Ingestible Sensor Manufacturing/Site Leader PROTEUS DIGITAL HEALTH, USA PLENARY SESSION THOUGHT LEADERS ENVER ERKAN Country Manager PFIZER, ALEXIS SERLIN Asia Cluster Head NOVARTIS, YARON TURPAZ Chief Data & Technology Officer, Managing Director GLOBAL GENE CORP, MIGUEL ANGEL RIVERA TAPIA Global Digital Innovation Lead, FERRING PHARMACEUTICALS, Switzerland HAZEL DY TIOCO Asia Pacific Regional Director, Study Management and Logistics, SANOFI, Philippines HARISH DAVE Chief Medical Officer, Executive Director, AUM BIOSCIENCES, LEADING REGIONAL DIGITAL PHARMA EXPERTS LAURENCE LIEW Director AI, JULIE OLSZEWSKI Executive Director, MSD Global Innovation Hub MSD, DR. PETER TING Co-Founder, Cadiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital, CHRIS WILLMOTT Regional Head of Business Effectiveness Asia Pacific Roche, WINSTON CHEW Director, Regional Information Security Officer GlaxoSmithKline, TAMSIN GREULICH-SMITH, Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of, JASON TAMARA WIDJAJA Associate Director, Global Data Science (AI & Data Products) MSD, RAFIQUL ISLAM IT Head- ADC Asia Pac, IT Business Relationship Abbott Laboratories, AARON TIAN Head of Neuroscience Patient Innovation UCB, China BRUCE SHI Chief Information Officer, Asia Sanofi, AMKIDIT AFABLE Director Business Model Innovation Asia Pacific Johnson & Johnson, JEAN-CHRISTOPHE DELUMEAU Head of Pharmacovigilance Policy Strategy Bayer, Co-located with Produced by Knowledge Partner

MAIN CONFERENCE DAY ONE 19 September 2018 Wednesday PharmaCon Asia Opening Plenary Session 09:00 KEYNOTE ADDRESS: - a Leading Innovation and Commercialization Hub in Asia Addressing on skilled

2 MAIN CONFERENCE DAY ONE 19 September 2018 Wednesday PharmaCon Asia Opening Plenary Session 09:00 KEYNOTE ADDRESS: - a Leading Innovation and Commercialization Hub in Asia Addressing on skilled talent, strong manufacturing capabilities and thriving research ecosystem in pharmaceutical firms to set up to serve patients and connect with the growing Asian market Ho Weng Si, Director, Biomedical Sciences Group, Economic Development Board, 09:20 INDUSTRY ADDRESS: Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines Nik Leist, Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health 09:40 INNOVATION TALK Innovation and Digitalisation The Impact and Where Do We Go Next? Scott Bales, Managing Director Innovation & Digital Transformation, Innovation Labs Asia Scott is a TEDx global thought leader and bestselling author, armed with a raw enthusiasm for technology and a fascination with people. A technology & innovation guru, a global leader in the cutting edge arena known as The Digital Shift, encompassing innovation, culture, design, and mobility in a world gone digital. As a thought leader, he thrives on the intersection between cultural and behavioural changes in the face of technology innovations. Aspiring to transform mainstream thought processing around conventional business practices, he has spoken at at TEDx, Social Media Week, Google Think, Fund Forum, Asian Banker, Next Money and a long list of private events. His thought leadership pieces on lead market expansion and innovation capability development in have appeared in WIRED, Australian Financial Review and E27. To listen to Scott s talk, click here 10:00 INDUSTRY THINK TANK: Pharma 2030 Envisioning the Future Drug pipeline growth areas Regulatory trends Innovation in pricing and market access The most significant industry trends in the long term, and how should Pharma respond Confirmed Panellists: Enver Erkan, Country Manager, Pfizer, Alexis Serlin, Asia Cluster Head, Novartis, Miguel Angel Rivera Tapia, Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland 10:40 Morning Networking and Refreshment Break Digital Pharma Summit Commences 11:10 Digital Pharma Chairman s Opening Remarks Trends in Digitalisation 11:15 Global Developments in Digitalisation of Pharmaceutical Snapshots on tech trends that are gaining traction Where are digital investments going? How can pharmaceutical companies leverage them in compliance with stringent regulations New regulatory framework to build trusted algorithms Ruediger Dorn, Director, Microsoft Corporation, US 11:45 CIO Interview: Progressing Digital Transformation in Pharma Bruce Shi, Chief Information Officer, Asia, Sanofi, Redefining Pharma - Consumer Interactions 12:20 Applications of Digital Technologies to Solve Big Barriers Delivery, Access, Financing, Customer Experience Innovating from customer s needs and perspectives Creating new healthcare models for better patient outcomes Amkidit Afable, Director Business Model Innovation Asia Pacific, Johnson & Johnson, 13:00 Networking Lunch 14:00 The Tale of 2 Innovative Business Transformations Leading Customer Engagement and Commercial Strategies Importance of staying engaged with consumers/patients Preparing for disruption Why MNCs are at risk of disruptions Chris Willmott, Regional Head of Business Effectiveness Asia Pacific, Roche, Richard Batchelder, Regional Business and Operations Director Roche Foundation Medicine, Roche, 14:30 Developing Innovative Technological Solutions to Improve Patient Outcomes Aaron Tian, Head of Neuroscience Patient Innovation, UCB, China Tech Showcase: Strategies to Seamlessly Integrated and Personalised Customer Experience and Patients Outcomes Online and Offline For speaking opportunities, please contact: Sheralin.See@ibcasia.com.sg 15:30 Afternoon Networking 16:00 Digitalisation of Pharmacovigilance and Adverse Effects Monitoring How can digitalisation and connected world play the part in monitoring better patient outcomes, drug performance and market dynamics of approved drugs? How is the deployment of smartphone seen as an access to global knowledge powered by AI in anyone s hand How can it trigger a revolution in pharmacovigilance and risk minimisation? Case studies to elaborate on the need for a versatile app to enforce educational risk minimization Jean-Christophe Delumeau, Head of Pharmacovigilance Policy Strategy, Bayer, 16:30 Digital Health: Delivering Personalised Medicine through Technology The rise of apps as medical devices The convergence between tech and pharma How artificial intelligence will make healthcare more efficient Miguel Angel Rivera Tapia, Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland Digital Innovation and Implementation 17:00 Enabling to Ride the AI Wave in Pharma 100 Experiments (100E) programme How the Pharma industry is benefiting Use cases of how AI is applied in the Pharma industry Laurence Liew, Director, AI, 17:30 Industry Panel: Digital Transformation in the Asian Context Examining the current impact of digitalisation in the Asian Pharma sector What touch points will have most influence How is Pharma - HCP Patient engagement going to change Pharma and Consumer interface evolution What is needed to give Pharma a digital boost Panellists: Prabhuram Krishnan, Medical Director (South Asia Hong Kong, ASEAN, India), Ipsen, Rafiqul Islam, IT Head- ADC Asia Pac, IT Business Relationship, Abbott Laboratories, Jason Tamara Widjaja, Associate Director, Global Data Science (AI & Data Products), MSD, (More panellists to be confirmed) 18:00 End of Conference Day 1, followed by networking cocktails

MAIN CONFERENCE DAY TWO 20 September 2018 Thursday Pharma HCP Relationships 9:00 Digitalising Pharma - HCP Engagement: Challenges, Opportunities and Benefits Julie Olszewski, Executive Director, MSD

increasing pervasiveness of digital and mobile communication platform Addressing technological advancement such as cloud, IoT, data analytics and AI Medical doctors experience on rapid change and

Paul Tan, Director, KPMG Healthcare & Life Sciences, 10:00 Digital Pharma and Precision Medicine in the Age of Data Science, Machine Learning and Real Time Analytics Yaron Turpaz, Chief Data &

, 10:30 Morning Networking and Refreshment Break Beyond the Pill 11:00 Case Study: Embracing Digitalisation- Creating a Value Chain in Pharma & Healthcare Trends of digital innovations in Pharma &

3 MAIN CONFERENCE DAY TWO 20 September 2018 Thursday Pharma HCP Relationships 9:00 Digitalising Pharma - HCP Engagement: Challenges, Opportunities and Benefits Julie Olszewski, Executive Director, MSD Global Innovation Hub, MSD, 9:30 How Digital Solutions Can Enhance the Patient, Doctor, and Pharma Pathways Experience Patient journey and their experience with medication is changing with the increasing pervasiveness of digital and mobile communication platform Addressing technological advancement such as cloud, IoT, data analytics and AI Medical doctors experience on rapid change and transformation from the impact of technology How can patients, doctors and pharma find the convergence and success in digital solutions and what good (experience) looks like? Paul Tan, Director, KPMG Healthcare & Life Sciences, 10:00 Digital Pharma and Precision Medicine in the Age of Data Science, Machine Learning and Real Time Analytics Yaron Turpaz, Chief Data & Technology Officer, Managing Director, Global Gene Corp., 10:30 Morning Networking and Refreshment Break Beyond the Pill 11:00 Case Study: Embracing Digitalisation- Creating a Value Chain in Pharma & Healthcare Trends of digital innovations in Pharma & Healthcare Challenges in adapting digitalization in these fields How digitalization will help to create value chain for the patients Mrunalini Jagtap, Data Management Lead, Institute for Clinical Sciences, Agency for Science, Technology and Research, 11:30 Use & Perception of Scientific Medical Reprints and Opportunities in Digital Marketing Amit Singh, Director Pharma Business, Elsevier, India 12:00 Emerging Medical Technologies and New Opportunities for Digital Pharma Overview of emerging trends in medical technologies, and extrapolation to future business opportunities for digital pharma Direct-to-consumer distribution and supply chain optimisation Dr. Dinesh Visva Gunaskeran, Steering Committee (Head, Big Data Protocol), Collaborative Ocular Tuberculosis Study, 14:00 The Impact of Technology in Reshaping the Thinking of Pharma Leaders Transformation, Investments, Business Strategies Tamsin Greulich-Smith, Chief, Smart Health Leadership Centre, Institute of Systems Science, National University of, 14:30 Pharma Case Study: Why Analytics Projects Fail? Starting out on analytics journeys common starting points that set you up for failure Problems with process right governance wrong place processes that set analytics up to fail Metric malfunction how managing an analytics department can look right on paper but still be worthless 3 big ideas that will help you avoid these pitfalls and get real value from analytics Jason Tamara Widjaja, Associate Director, Global Data Science (AI & Data Products), MSD, 15:00 Data Storage, Data Integrity, Privacy and Protection Will this be a barrier for pharma companies to digitally transform? How can traditional practices be seamlessly transform to accommodate to the digital age s needs? Winston Chew, Director, Regional Information Security Officer, GlaxoSmithKline, 15:30 Afternoon Networking Closing Plenary Session 16:00 PHARMACON ASIA 2018 ROUND-UP PANEL Closing Plenary Roundtable: Evolving scenarios for the Asian Pharma Market Top line innovation trends and implications Drug research and development environment in the long term Impact of M&A activity and investment on industry Emerging pharma business models, broadening value propositions, and sustainable revenue models Panellists: Hazel Dy Tioco, Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines Yaron Turpaz, Chief Data & Technology Officer, Managing Director, Global Gene Corp, Harish Dave, Chief Medical Officer, Executive Director, AUM Biosciences, (more panellists to be confirmed) 17:00 Chairperson s Summary of the Day and End of Conference Networking Lunch 13:30 Case Study: Preventing the Risk of Cardiovascular Disease via Doctor Patient Consumer Digital Platform Dr. Peter Ting, Co-Founder, Cardiatrics, Senior Consultant Cardiologist, Gleneagles and Mt. Elizabeth Hospital,

WORKSHOPS 18-21 September 2018 TUESDAY, 18 SEPTEMBER 2018. 9.00AM 1.

00PM: ENABLING REAL TIME AND DATA FOR PHARMA EXECUTIVES DECISION MAKING Digitalisation is an important part of pharmaceutical business be it multi-channel marketing strategy, streamlining business

4 WORKSHOPS September 2018 TUESDAY, 18 SEPTEMBER AM 1.00PM: DIGITAL PHARMA 101 KICK STARTING YOUR DIGITAL STRATEGY FRIDAY, 21 SEPTEMBER AM 1.00PM: ENABLING REAL TIME AND DATA FOR PHARMA EXECUTIVES DECISION MAKING Digitalisation is an important part of pharmaceutical business be it multi-channel marketing strategy, streamlining business workflows, understanding products performance, ROI, tracking pharmacovigilance and other practical applications. This workshop will give you workable ideas, tools and techniques to start planning your digital strategy. KEY LEARNING OUTCOMES Identify digital maturity across all areas and operations in your company Explore ways to integrate digital into commercial strategies, business workflows and operations Discuss different tools for various kinds of applications Design your own digital strategy Big data, artificial intelligence, machine learning, predictive analytics and many other buzzwords are the talks of the town right now. Technologies are coming into place to revolutionize industries. In this session, learn how big data and AI are impacting the pharma industry. What are the barriers to overcome? How can decisions be made via technology? How reliable are they? What do these data mean? KEY LEARNING OUTCOMES Understand how big data and AI work Find out how we can improve decision making use of AI solutions Explore applications of real-time data, and how can we make sense out of these data collected Examine case studies and assess risks and opportunities WHO YOU WILL MEET BY COUNTRY...75% Malaysia... 10% South East Asia...7% North Asia... 5% Europe and Australia... 2% Rest of the world... 1% BY INDUSTRY Pharmaceutical Companies... 65% Technology Provides...20% Contract Manufacturing Organizations... 5% Financial Advisory and Healthcare Consultant... 5% Government Agencies... 5% FIND OUT THE LATEST TRENDS AND OUTLOOK FOR DIGITALISATION NETWORK WITH LOCAL AND INTERNATIONAL EXPERTS EXPLORE NEW BUSINESS MODELS AND INNOVATIVE PARTNERSHIPS IN THE ECOSYSTEM BUILD SUCCESSFUL HCP CUSTOMER RELATIONSHIPS Media Partners

5 The digital revolution is disrupting and transforming across different business sectors and the pharmaceutical industry is not spared. With the theme on Redefining the Pharma HCP Customers Relationships, Digital Pharma Summit will showcase the global pharmaceutical industry technology outlook, new trends, innovative implementation strategies, investments, industry case studies on digitalisation projects amongst others. Part of IBC s 5th Annual PharmaCon Asia 2018, which is the preeminent meeting place for pharmaceutical industry professionals in the region. From Clinical Trials to Market Access to Digital Pharma, and against the bedrock of Regulatory Compliance, PharmaCon Asia will bring to you the full spectrum of the drug development and commercialisation value chain. 4 CO LOCATED CONFERENCES 70+ EXPERT INSIGHTS 280+ TOTAL PARTICIPANTS 5TH PHARMACON ASIA AGENDA AT A GLANCE Trends in Digitalisation Redefining Pharma Consumer Interactions Regional Trends in Pharma 4.0 Pharma-HCP Relationships Beyond the Pill Enabling Digitalisation Global Regulatory Affairs Updates Global Regulatory Operation Models & e-labelling Drug Development and Regulatory Landscapes Regulatory Strategy and Access Regulatory Compliance and Post-Approval Considerations Emerging Markets and Growth Segments HEOR and RWE for Market Entry and Expansion Innovative Pharma- Stakeholder Collaboration Models Value-Based Price Modelling and Reimbursement Strategies Orphan Drugs and Innovative Medicine Tech in Trials Clinical Trial Markets in, Malaysia, Indonesia, Philippines Optimising Trial Outcomes Disease Specific Trials Innovation in Critical Treatment Trials PARTNERSHIP OPPORTUNITIES NOW AVAILABLE UNRIVALLED OPPORTUNITY TO PROFILE YOUR COMPANY! With a demonstrated track record, 5th Annual PharmaCon Asia is your one stop shop to reach out to top decision makers. We will be glad to discuss customized options that suit your budget. STRATEGIC BRANDING Profile your organisation as an industry leader and leverage on our integrated marketing campaign to extend your marketing reach. PRODUCT SHOW Showcase your products and solutions and engage your targeted audience through the exhibition stands or table displays. NETWORKING FUNCTIONS Engage your captive audience at an exclusive event hosted by your organisation. ONSITE BRANDING Reinforce your branding and seize the opportunity to enhance your brand visibility at the event. Sponsorship & Exhibition Opportunities Available - Please contact: MS. YVONNE LEONG TEL: MOBILE: YVONNE.LEONG@IBCASIA.COM.SG

Digital Health Startups A FirstWord ExpertViews Dossier Report

Digital Health Startups A FirstWord ExpertViews Dossier Report AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in